Teva Pharmaceutical Industries Limited - Asset Resilience Ratio

Latest as of December 2018: 0.00%

Teva Pharmaceutical Industries Limited (TEV) has an Asset Resilience Ratio of 0.00% as of December 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Teva Pharmaceutical Industries Limited strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

€2.00 Million

≈ $2.34 Million USD Cash + Short-term Investments

Total Assets

€60.68 Billion

≈ $70.94 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2018)

This chart shows how Teva Pharmaceutical Industries Limited's Asset Resilience Ratio has changed over time. See TEV net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Teva Pharmaceutical Industries Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Teva Pharmaceutical Industries Limited market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€2.00 Million	0.0%
Total Liquid Assets	€2.00 Million	0.00%

Asset Resilience Insights

Limited Liquidity: Teva Pharmaceutical Industries Limited maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Teva Pharmaceutical Industries Limited Industry Peers by Asset Resilience Ratio

Compare Teva Pharmaceutical Industries Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Haleon plc NYSE:HLN	Drug Manufacturers - Specialty & Generic	4.06%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	0.29%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	6.06%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	3.28%
Shenzhen Chipscreen Biosciences Co SHG:688321	Drug Manufacturers - Specialty & Generic	5.10%
Tianjin Ringpu Bio Tech SHE:300119	Drug Manufacturers - Specialty & Generic	14.27%
China Animal Husbandry Industry Co Ltd SHG:600195	Drug Manufacturers - Specialty & Generic	3.81%
Shandong Shanda Wit Science and Technology Co Ltd SHE:000915	Drug Manufacturers - Specialty & Generic	25.22%

Annual Asset Resilience Ratio for Teva Pharmaceutical Industries Limited (2015–2018)

The table below shows the annual Asset Resilience Ratio data for Teva Pharmaceutical Industries Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2018-12-31	0.00%	€2.00 Million ≈ $2.34 Million	€60.68 Billion ≈ $70.94 Billion	-0.02pp
2017-12-31	0.02%	€14.00 Million ≈ $16.37 Million	€70.61 Billion ≈ $82.56 Billion	-0.71pp
2016-12-31	0.73%	€679.00 Million ≈ $793.82 Million	€92.89 Billion ≈ $108.60 Billion	+0.71pp
2015-12-31	0.02%	€11.00 Million ≈ $12.86 Million	€54.23 Billion ≈ $63.40 Billion	--

pp = percentage points

About Teva Pharmaceutical Industries Limited

F:TEV Germany Drug Manufacturers - Specialty & Generic

Market Cap

$41.38 Billion

€35.40 Billion EUR

Market Cap Rank

#782 Global

#169 in Germany

Share Price

€30.40

Change (1 day)

+16.03%

52-Week Range

€13.15 - €30.50

All Time High

€57.25